Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonist.
Gupta S, Malhotra S, Sinha S, Singh SK, Singh RK, Krishna S, Chhabra P, Chaira T, Kannayiram J, Sharma P, Aeron S, Kaur J, Kumar N, Sattigeri J, Shirumalla RK, Paliwal J, Dastidar SG, Cliffe IA, Ray A, Bhatnagar P. Gupta S, et al. Among authors: sattigeri j. Eur J Pharmacol. 2011 May 11;658(2-3):219-28. doi: 10.1016/j.ejphar.2011.02.024. Epub 2011 Mar 1. Eur J Pharmacol. 2011. PMID: 21371471
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, Ahmed S, Sattigeri J, Cliff I, Ray A, Bansal VS, Bhatnagar PK, Davis JA. Singh S, et al. Among authors: sattigeri j. Eur J Pharmacol. 2011 Feb 10;652(1-3):157-63. doi: 10.1016/j.ejphar.2010.06.001. Epub 2010 Jun 9. Eur J Pharmacol. 2011. PMID: 20540938
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.
Sattigeri JA, Sethi S, Davis JA, Ahmed S, Rayasam GV, Jadhav BG, Chilla SM, Datta D, Gadhave A, Tulasi VK, Jain T, Voleti S, Benjamin B, Udupa S, Jain G, Singh Y, Srinivas K, Bansal VS, Ray A, Bhatnagar PK, Cliffe IA. Sattigeri JA, et al. Bioorg Med Chem Lett. 2017 Jun 1;27(11):2313-2318. doi: 10.1016/j.bmcl.2017.04.036. Epub 2017 Apr 13. Bioorg Med Chem Lett. 2017. PMID: 28442252
Novel fluorobenzothiazole as a dual inhibitor of gyrase B and topoisomerase IV against Gram-positive pathogens.
Barman TK, Kumar M, Chaira T, Singhal S, Mathur T, Kalia V, Gangadharan R, Rao M, Pandya M, Bhateja P, Sood R, Upadhyay DJ, Varughese S, Yadav A, Sharma L, Ramadass V, Kumar N, Sattigeri J, Bhatnagar PK, Raj VS. Barman TK, et al. Among authors: sattigeri j. Future Microbiol. 2023 Jul;18:625-638. doi: 10.2217/fmb-2022-0207. Epub 2023 Jun 22. Future Microbiol. 2023. PMID: 37347211
Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors.
Sattigeri JA, Garg M, Bhateja P, Soni A, Rauf ARA, Gupta M, Deshmukh MS, Jain T, Alekar N, Barman TK, Jha P, Chaira T, Bambal RB, Upadhyay DJ, Nishi T. Sattigeri JA, et al. Bioorg Med Chem Lett. 2018 Sep 15;28(17):2993-2997. doi: 10.1016/j.bmcl.2018.06.017. Epub 2018 Jun 12. Bioorg Med Chem Lett. 2018. PMID: 30017316
11 results